Intestinal Parasitic Infection-Induced Intestinal Wall Cytoskeleton Dysfunction in Diabetes Mellitus
DOI:
https://doi.org/10.60787/njgp.v20i1.7Keywords:
ultrasound, tropical diseases, parasites, gastrointestinal tract, DiabetesAbstract
Background: The gastrointestinal tract (GIT) could harbor intestinal parasitic infections (IPIs) alongside a dense and diverse microbial
community, termed GIT microbiome. We examined the role of IPI-related changes in intestinal echoanatomy in the pathophysiology of
type 2 diabetes mellitus (T2DM).
Methods: The study included 95 subjects (44 males and 51 females). The diagnosis was based on clinical presentation and laboratory tests, including serial stool microscopy for IPIs, and for diabetes, measurement of hemoglobin A1C, fasting or random blood glucose level, or oral glucose tolerance testing. The B-mode ultrasound grayscale and color images using a high-frequency phased array transducer of 7.5 MHz of the duodenum and colon were obtained with and without water contrast. The duodenal wall thickness was used as measurement endpoint.
Results: Eighty consecutive patients had at least one type of IPIs in serial stool microscopy, and 15 were healthy persons. Among the 80 IPI patients, 52 (65%) were diabetic, and 28 (35%) patients were nondiabetic. We demonstrated normal duodenum and colon echoanatomy in healthy persons. In patients with IPIs, the duodenal wall thickness (6.87 ± 2.09 mm) was greater than that in healthy persons (3.5 ± 1.07 mm) (P < 0.001). In diabetic patients, the duodenal wall thickness (7.23 ± 2.1 mm) was greater than that in nondiabetic patients (5.26 ± 2.07 mm) (P < 0.001). There were main effects of age and obesity but not sex. Antiparasitic treatment of IPIs alongside antidiabetic drugs improved control of fasting blood sugar.
Conclusion: Ultrasound duodenography and colonography demonstrated IPI-induced intestinal wall thickening with rearrangement of the cytoskeleton, causing malfunction of the glucose transporter system which resulted in T2DM.
Downloads
References
McDermott AJ, Huffnagle GB. The microbiome and regulation of mucosal immunity. Immunology 2014;142:24-31.
World Health Organization. World Health Report. Conquering Suffering Enriching Humanity. Geneva: WHO; 1997. Available from: http://apps.who.int/bookorders/MDIbookPDF/Book/12401997.pdf. [Last accessed on 2017 Jul 22].
Bahmani P, Maleki A, Sadeghi S, Shahmoradi B, Ghahremani E. Prevalence of intestinal protozoa infections and associated risk factors among schoolchildren in Sanandaj City, Iran. Iran J Parasitol 2017;12:108-16.
Quihui L, Valencia ME, Crompton DW, Phillips S, Hagan P, Morales G, et al. Role of the employment status and education of mothers in the prevalence of intestinal parasitic infections in Mexican rural schoolchildren. BMC Public Health 2006;6:225.
Barry MA, Weatherhead JE, Hotez PJ, Woc-Colburn L. Childhood parasitic infections endemic to the United States. Pediatr Clin North Am 2013;60:471-85.
Gyang VP, Chuang TW, Liao CW, Lee YL, Akinwale OP, Orok A, et al. Intestinal parasitic infections: Current status and associated risk factors among school aged children in an archetypal African urban slum in Nigeria. J Microbiol Immunol Infect 2019;52:106-13.
Boulangé CL, Neves AL, Chilloux J, Nicholson JK, Dumas ME. Impact of the gut microbiota on inflammation, obesity, and metabolic disease.
Genome Med 2016;8:42.
Sohail MU, Althani A, Anwar H, Rizzi R, Marei HE. Role of the gastrointestinal tract microbiome in the pathophysiology of diabetes mellitus. J Diabetes Res 2017;2017:9631435.9. Scheithauer TP, Rampanelli E, Nieuwdorp M, Vallance BA, Verchere CB, van Raalte DH, et al. Gut microbiota as a trigger for metabolic inflammation in obesity and type 2 diabetes. Front Immunol 2020;11:571731.
Kelly TN, Bazzano LA, Ajami NJ, He H, Zhao J, Petrosino JF, et al. Gut microbiome associates with lifetime cardiovascular disease risk profile
among bogalusa heart study participants. Circ Res 2016;119:956-64.
Paras TM, Percival F, McQuade E. The gut microbiome influences arthritis development in IIJ mice. J Immunol 2016;196:118.16.
Rosshart SP, Vassallo BG, Angeletti D, Hutchinson DS, Morgan AP, Takeda K, et al. Wild mouse gut microbiome protects laboratory mice against lethal influenza virus infection and colorectal cancer. J Immunol 2017;198:68.5.
Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3:e442.
Chen L, Tuo B, Dong H. Regulation of intestinal glucose absorption by ion channels and transporters. Nutrients 2016;8:43.
Gorboulev V, Schürmann A, Vallon V, Kipp H, Jaschke A, Klessen D, et al. Na(+)-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion. Diabetes 2012;61:187-96.
Reimann F, Habib AM, Tolhurst G, Parker HE, Rogers GJ, Gribble FM. Glucose sensing in L cells: A primary cell study. Cell Metab 2008;8:532-9.
GribbleFM, WilliamsL, SimpsonAK, ReimannF. Anovel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the
GLUTag cell line. Diabetes 2003;52:1147-54.
Röder PV, Geillinger KE, Zietek TS, Thorens B, Koepsell H, Daniel H. The role of SGLT1 and GLUT2 in intestinal glucose transport and sensing. PLoS One 2014;9:e89977.
Boudry G, Cheeseman CI, Perdue MH. Psychological stress impairs Na+-dependent glucose absorption and increases GLUT2 expression
in the rat jejunal brush-border membrane. Am J Physiol Regul Integr Comp Physiol 2007;292:R862-7.
Chaudhry RM, Scow JS, Madhavan S, Duenes JA, Sarr MG. Acute enterocyte adaptation to luminal glucose: Aposttranslational mechanism for rapid apical recruitment of the transporter GLUT2. J Gastrointest Surg 2012;16:312-9.
Affleck JA, Helliwell PA, Kellett GL. Immunocytochemical detection of GLUT2 at the rat intestinal brush-border membrane. J Histochem Cytochem 2003;51:1567-74.
Zheng Y, Scow JS, Duenes JA, Sarr MG. Mechanisms of glucose uptake in intestinal cell lines: Role of GLUT2. Surgery 2012;151:13-25.
Grefner NM, Gromova LV, Gruzdkov AA, Komissarchik I. Interaction of glucose transporters SGLT1 and GLUT2 with cytoskeleton in enterocytes and caco2 cells during hexose absorption. Cell Tissue Biol 2015;9:45-52.
Hakim GD, Kızıltaş S, Ciftçi H, Göktaş S, Tuncer I. The prevalence of giardia intestinalis in dyspeptic and diabetic patients. ISRN Gastroenterol 2011;2011:580793.
Njemanze PC, Njemanze J, SkeltonA, AkudoA, Akagha O, ChukwuAA, et al. High-frequency ultrasound imaging of the duodenum and colon in
patients with symptomatic giardiasis in comparison to amebiasis and healthy subjects. J Gastroenterol Hepatol 2008;23:e34-42.
Njemanze PC, Njemanze JT, Ofoegbu CC, Darlington CC, Nneke E, Onweni JA, et al. High-frequency ultrasound imaging of the intestine in normal subjects and patients with intestinal parasites. In: Ali Abdo Gamie S, Mahmoud Foda E, editors. Essentials of Abdominal Ultrasound. London: IntechOpen; 2019. p. 91-105.
Njemanze PC, Njemanze JT, Ofoegbu CC, Nneke E, Onweni IA, Ejiogu UV, et al. Technical notes on highfrequency ultrasound duodenography and colonography imaging of giardial lesions. Niger J Gen Pract 2021;19:54-60.
Li Z, Elliott E, Gunning P, O’Loughlin E. Does the cytoskeleton of intestinal epithelial cells function as a celluar alarm to identify the E. coli infection. J Gastroenterol Hepatol 2001;16:33.
American Diabetes Association. 2. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2020. Diabetes Care 2020;43:S14-31.
Cheesbrough M. Medical Laboratory Manual for Tropical Countries. 2nd ed., Vol. 1. Oxford: ELBS with Tropical Health Technology/Butterworth-Heinemann Ltd.; 1992. p. 208-14.
Petri WA Jr. Therapy of intestinal protozoa. Trends Parasitol 2003;19:523-6.
Horton J. Albendazole: A review of anthelmintic efficacy and safety in humans. Parasitology 2000;121 Supp l: S113-32.
American Diabetes Association. 9. Pharmacologic approaches to glycemic treatment: Standards of medical care in diabetes-2021. Diabetes Care 2021;44:S111-24.
de Silva NR, Brooker S, Hotez PJ, Montresor A, Engels D, Savioli L. Soil-transmitted helminth infections: Updating the global picture. Trends Parasitol 2003;19:547-51.
Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Capristo E, et al. Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial. Lancet 2021;397:293-304.
Published
Issue
Section
License
Copyright (c) 2024 Nigerian Journal of General Practice
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
How to Cite
